Shots:Aqua Medical has received the US FDA IDE approval to initiate the RESTORE-1 study evaluating the Proximal Intestinal Mucosal Ablation (PIMA) procedure using its radiofrequency vapor ablation (RFVA) system in adults with uncontrolled type 2 diabetesThe IDE approval was backed by international data showing safety & metabolic benefits of PIMA, allowing Aqua Medical…
